Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults

Clinical Chemistry

Volumn 47, Issue 3, 2001, Pages 444-450

  Ockene, I S ^a   Matthews, C E ^a   Rifai, N ^a   Ridker, P M ^a   Reed, G ^a   Stanek, E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PERIODIC MEDICAL EXAMINATION; PROTEIN ANALYSIS;

EID: 0035103150     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.3.444     Document Type: Article

References (38)

1. Low grade inflammation and coronary heart disease: Pro-spective study and updated meta-analyses
2. Inflammation, aspirin, the risk of cardiovascular disease in apparently healthy men
3. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
4. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
5. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project
6. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
7. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
8. C-Reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
9. C-Reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
10. Novel inflammatory markers of coronary risk: Theory versus practice
11. Statins and C-reactive protein
12. Effect of statins on C-reactive protein in patients with coronary artery disease
13. Acute-phase proteins and other systemic responses to inflammation
14. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications
15. A rapid and sensitive automated light scattering immunoassay for serum C-reactive protein and the definition of a reference range in healthy blood donors
16. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects
17. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease
18. C-Reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
19. Long-term effects of pravastatin on plasma concentration of C-reactive protein The Cholesterol and Recurrent Events (CARE) Investigators
20. Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris
21. Seasonal variation of blood cholesterol levels: Study methodology
22. Rhinovirus infections in an industrial population I The occurrence of illness
23. The epidemiology of acute respiratory infections in children and adults: A global perspective
24. Evaluation of cholesterol measurement with the Beckman System 700 analyzer in the Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program
25. Enzymatic determination of total serum cholesterol
26. Quantitative determination of serum triglycerides by the use of enzymes
27. A comprehensive evaluation of the heparinmanganese precipitation procedure for estimating high density lipoprotein cholesterol
28. Estimation of plasma low-density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge
29. Clinical efficacy of an automated high-sensitivity C-reactive protein assay
30. Elevated C-reactive protein levels in overweight and obese adults
31. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
32. Summary of the second report of the National Cholesterol Education Program (NCEP)Expert Panel On Detection, Evaluation, and Treatment Of High Blood Cholesterol In Adults (Adult Treatment Panel II)
33. C-Reactive protein and risks of future myocardial infarction and thrombotic stroke
34. Generation and application of data on biological variation in clinical chemistry
35. Range of serum cholesterol values in the population developing coronary artery disease
36. Evaluating novel cardiovascular risk factors: Can we better predict heart attacks?